Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women

The RV144 HIV-vaccine trial highlighted the importance of envelope-specific non-neutralizing antibody (nNAb) Fc-mediated functions as immune correlates of reduced risk of infection. Since pre-exposure prophylaxis (PrEP) and HIV-vaccines are being used as a combination prevention strategy in at risk...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Fisher, Kimone Leigh, Mabuka, Jennifer M., Sivro, Aida, Ngcapu, Sinaye, Passmore, Jo-Ann Shelley, Osman, Farzana, Ndlovu, Bongiwe, Abdool Karim, Quarraisha, Abdool Karim, Salim S., Chung, Amy W., Baxter, Cheryl, Archary, Derseree
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7357346/
https://ncbi.nlm.nih.gov/pubmed/32733445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01274
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars